A multi-estuary assessment of pharmaceutical exposure and risk of pharmacological effects in a recreational fishery
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60076658%3A12520%2F25%3A43910078" target="_blank" >RIV/60076658:12520/25:43910078 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.1093/etojnl/vgaf125" target="_blank" >https://doi.org/10.1093/etojnl/vgaf125</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/etojnl/vgaf125" target="_blank" >10.1093/etojnl/vgaf125</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
A multi-estuary assessment of pharmaceutical exposure and risk of pharmacological effects in a recreational fishery
Popis výsledku v původním jazyce
Evidence of coastal and marine pharmaceutical pollution is increasing, yet most studies examining pharmaceuticals are conducted in temperate regions, while research in subtropical and tropical regions lags behind. These studies have been conducted at small spatial scales, with a need for larger spatial assessments. We examined pharmaceutical occurrence and pharmacological risk for 94 pharmaceuticals in a coastal recreational fish, the red drum (Sciaenops ocellatus), across nine Florida (USA) estuaries. To evaluate risk of pharmacological effects, we compared plasma concentrations to the one-third human therapeutic plasma concentration (1/3 HTPC) and to the full HTPC. Pharmaceuticals were detected in all estuaries and in 93% of plasma samples analyzed, with an average of 2.1 pharmaceuticals per red drum. A total of 17 pharmaceuticals were detected, and dissimilarity in the pharmaceutical assemblage across estuaries was high. Cardiovascular medications, opioid pain relievers, and psychoactive medications accounted for 90.6% of detections. For pharmacological effects, we observed medium risk in 25.7% and high risk in 15.9% of the red drum sampled. Of the 17 pharmaceuticals detected, five were observed at concentrations above the 1/3 HTPC, with a psychoactive pharmaceutical (flupentixol) showing the highest pharmacological risk. Across estuaries, risk of pharmacological effects was observed in five of nine estuaries, with 33%-60% of the red drum above the 1/3 HTPC threshold, whereas risk was minimal in the other four estuaries (only 0%-7% exceedances). Pharmacological risk was highest on the west coast of Florida and in both large and densely-populated watersheds, as well as small and sparsely populated ones. Our findings highlight the need expand beyond documenting occurrence to estimating toxicological risk, the value of assessing internal concentrations in wild biota, and the importance of expanding the diversity of biota used in pharmaceutical studies to account for pharmacological effects in conservation and management actions, such as recreational fisheries.
Název v anglickém jazyce
A multi-estuary assessment of pharmaceutical exposure and risk of pharmacological effects in a recreational fishery
Popis výsledku anglicky
Evidence of coastal and marine pharmaceutical pollution is increasing, yet most studies examining pharmaceuticals are conducted in temperate regions, while research in subtropical and tropical regions lags behind. These studies have been conducted at small spatial scales, with a need for larger spatial assessments. We examined pharmaceutical occurrence and pharmacological risk for 94 pharmaceuticals in a coastal recreational fish, the red drum (Sciaenops ocellatus), across nine Florida (USA) estuaries. To evaluate risk of pharmacological effects, we compared plasma concentrations to the one-third human therapeutic plasma concentration (1/3 HTPC) and to the full HTPC. Pharmaceuticals were detected in all estuaries and in 93% of plasma samples analyzed, with an average of 2.1 pharmaceuticals per red drum. A total of 17 pharmaceuticals were detected, and dissimilarity in the pharmaceutical assemblage across estuaries was high. Cardiovascular medications, opioid pain relievers, and psychoactive medications accounted for 90.6% of detections. For pharmacological effects, we observed medium risk in 25.7% and high risk in 15.9% of the red drum sampled. Of the 17 pharmaceuticals detected, five were observed at concentrations above the 1/3 HTPC, with a psychoactive pharmaceutical (flupentixol) showing the highest pharmacological risk. Across estuaries, risk of pharmacological effects was observed in five of nine estuaries, with 33%-60% of the red drum above the 1/3 HTPC threshold, whereas risk was minimal in the other four estuaries (only 0%-7% exceedances). Pharmacological risk was highest on the west coast of Florida and in both large and densely-populated watersheds, as well as small and sparsely populated ones. Our findings highlight the need expand beyond documenting occurrence to estimating toxicological risk, the value of assessing internal concentrations in wild biota, and the importance of expanding the diversity of biota used in pharmaceutical studies to account for pharmacological effects in conservation and management actions, such as recreational fisheries.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10511 - Environmental sciences (social aspects to be 5.7)
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Environmental toxicology and chemistry
ISSN
0730-7268
e-ISSN
1552-8618
Svazek periodika
44
Číslo periodika v rámci svazku
10
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
16
Strana od-do
2832-2847
Kód UT WoS článku
001554213500001
EID výsledku v databázi Scopus
2-s2.0-105017694777